• HATU in Peptide Synthesis Chemistry: Optimizing Amide Format

  2026-06-02

  HATU enables highly efficient, selective amide bond formation in cutting-edge peptide synthesis chemistry and inhibitor design. This article bridges detailed protocol guidance, troubleshooting expertise, and insights from recent IRAP inhibitor research to help researchers maximize yield and selectivity with HATU.

• Viral-Mediated RIPK3 Degradation Modulates Necroptosis and I

  2026-06-01

  The referenced study identifies a novel class of viral proteins that promote proteasomal degradation of the necroptosis adaptor RIPK3, thereby regulating virus-induced inflammation and pathogenesis in orthopoxvirus infections. These findings redefine our understanding of viral immune evasion and provide a foundation for future research on cell death modulation and antiviral strategies.

• GW4064: Non-Steroidal FXR Agonist for Metabolic Research

  2026-06-01

  GW4064, a potent non-steroidal FXR agonist, enables precise modulation of bile acid and lipid metabolism in preclinical studies. Its nanomolar potency and selectivity make it a gold standard tool for investigating FXR signaling pathways and their impact on metabolic and fibrotic processes.

• Indometacin Sodium: Protocols, Assay Optimization & Pitfalls

  2026-05-31

  Indometacin Sodium Trihydrate offers unmatched versatility for anti-inflammatory and regenerative research, supporting precise control of prostaglandin synthesis and advanced signaling modulation. This guide delivers actionable workflows, troubleshooting insights, and protocol parameters for maximizing reproducibility and translational impact across inflammation and neuroregeneration models.

• Neuroligin 1 Proteolysis Sustains Social Memory via Cofilin

  2026-05-30

  Liu et al. (2025) reveal a previously unknown mechanism in which social interaction-induced proteolytic processing of Neuroligin 1 (NLG1) in the ventral hippocampus generates a C-terminal fragment essential for maintaining social memory. This work clarifies how extracellular cues translate into synaptic remodeling via the cofilin pathway, offering new directions for studying memory maintenance and neuropsychiatric disorders.

• Clodronate Liposomes: Precision In Vivo Macrophage Depletion

  2026-05-29

  Clodronate Liposomes empower targeted, reproducible in vivo macrophage depletion for immunology and transplantation research. This guide details optimized workflows, experimental breakthroughs, and troubleshooting strategies to harness the full potential of liposome-encapsulated clodronate.

• 2'3'-cGAMP (sodium salt): Reliable STING Agonist for Assay R

  2026-05-29

  This article explores real-world laboratory scenarios where 2'3'-cGAMP (sodium salt) (SKU B8362) from APExBIO delivers data-backed solutions to common challenges in cell viability, proliferation, and immune signaling assays. Using recent literature and validated best practices, we address workflow reliability, experimental design, and interpretation for STING pathway research.

• Targeting Cell Surface RNA-Binding Proteins in AML Therapy

  2026-05-28

  A recent study in Nature Biotechnology identifies cell surface nucleophosmin (csNPM1) as a tumor-selective antigen in acute myeloid leukemia (AML), enabling the development of a monoclonal antibody with robust anti-tumor efficacy and minimal toxicity. This discovery broadens the landscape of cell surface targets in AML and has implications for both diagnostic and therapeutic strategies.

• Renalase Drives Aldosterone via PMCA4b/cAMP in Adrenocortica

  2026-05-28

  This study reveals that renalase directly stimulates aldosterone production in human adrenocortical cells by binding the PMCA4b receptor and activating cAMP/PKA signaling, bypassing classical calcium pathways. The findings highlight a previously unappreciated mechanism in aldosterone regulation, with implications for understanding primary aldosteronism and cardiovascular risk.

• Indomethacin as a Precision Tool for Adipocyte and Membrane

  2026-05-27

  Explore how Indomethacin, a nonsteroidal anti-inflammatory drug, enables advanced inflammation research and membrane signaling modulation. This article delivers a unique, protocol-driven perspective on leveraging Indomethacin in adipocyte differentiation and lipid metabolism studies, with actionable insights distinct from prior content.

• GW4064: Potent Non-Steroidal FXR Agonist for Metabolic Resea

  2026-05-27

  GW4064 is a highly selective non-steroidal FXR agonist used in metabolic research to probe bile acid, cholesterol, and triglyceride regulation. Its low nanomolar potency and specificity make it an industry benchmark for FXR pathway studies, though its therapeutic use is limited by solubility and stability constraints.

• Pseudo-modified Uridine Triphosphate for mRNA Synthesis Exce

  2026-05-26

  Pseudo-UTP empowers researchers to craft highly stable, low-immunogenicity mRNAs, revolutionizing workflows in mRNA vaccine development and gene therapy. This article details best practices, stepwise protocols, and troubleshooting strategies for incorporating Pseudo-modified uridine triphosphate into advanced RNA synthesis and delivery platforms.

• Ciclesonide: Mechanistic Leverage and Strategic Impact in Tr

  2026-05-26

  Explore how Ciclesonide’s prodrug activation and potent glucocorticoid receptor binding drive anti-inflammatory efficacy in asthma and allergic rhinitis research. This article connects the compound's mechanistic precision to ERAD-hijacking advances in targeted protein degradation, offering translational researchers actionable guidance and protocol insights for maximizing reproducibility and clinical relevance.

• O-GlcNAcylation Links Wnt Signaling to Bone Formation via Gl

  2026-05-25

  This study reveals that O-GlcNAcylation is essential for Wnt-induced osteogenesis by rewiring aerobic glycolysis. The findings illuminate a metabolic mechanism for bone formation, with implications for osteoporosis research and Wnt pathway modulation.

• Artemisinin Prevents Diabetic Cognitive Decline via NRF2 Pat

  2026-05-25

  Wang et al. (2024) uncover a mechanistic link between artemisinin-mediated NRF2 pathway activation and the inhibition of hippocampal neuronal ferroptosis in type 2 diabetic mice, leading to improved cognitive function. Their findings highlight the central role of NRF2 in neuroprotection and suggest new directions for diabetes-associated cognitive impairment research.

415 records 7/28 page Previous Next First page 上5页 678910 下5页 Last page